| Go Pro | AZ1 Chatter | IMYO FYI | Tell your friends and family about NICHEY & AZ1 |

HR+ HER2- breast cancer is the most common subtype, making up around 70% of all breast cancer cases. Characterized by hormone receptor positivity and the absence of HER2 overexpression, the prevalence of HR+ HER2- breast cancer varies globally.